Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Back Pain
Teriparatide tested against alendronate for back pain in women with osteoporosis
October 13th, 2005
Teriparatide was tested against alendronate for back pain in women with osteoporosis. "To compare the effects on back pain of teriparatide versus alendronate," scientists in the United States conducted a study to "analyze the reporting of back pain in a head to head comparator trial and a followup study. In the comparator trial, women were randomized to receive either daily self-injected teriparatide 40 micro g plus an oral placebo (n=73), or daily oral alendronate 10 mg plus self-injected placebo (n=73)." "Treatment was for a median 14 months," stated P. D. Miller and colleagues. "After completion of the comparator trial, 72% of these patients...
Source: Women's Health Weekly (2005-10-13)
|
